3 Comments

IntegenX Raises $15.6M, Buys VC-backed GenVault

Genetic analysis company IntegenX has raised $15.6 million in venture capital, and acquired biotech company GenVault Corp. Life science investor Domain Associates led the round, which included participation from previous investors In-Q-Tel and RONAholdings LLC. GenVault’s existing investors QuestMark Partners, Cross Creek Partners, and Greenspring Associates now join the syndicate backing IntegenX. Pleasanton, Calif.-based IntegenX designs, manufactures and markets automated DNA and RNA based sample preparation.

PE HUB Community

Join the 12522 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget